Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
100 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DOMPERIDONE | 10MG | TABLET | Resolved | 2024-02-29 | 2024-05-16 | 220980 |
| TEVA-DOMPERIDONE | 10MG | TABLET | Resolved | 2020-09-11 | 2020-12-17 | 124104 |
| TEVA-DONEPEZIL | 5MG | TABLET | Resolved | 2020-07-09 | 2021-04-21 | 119892 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-07-14 | 2021-07-09 | 120229 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-07-14 | 2020-10-22 | 120232 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42629 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2020-12-17 | 2021-07-09 | 130301 |
| TEVA-DONEPEZIL | 5MG | TABLET | Actual shortage | 2025-01-30 | 2025-04-10 | 249207 |
| TEVA-DONEPEZIL | 10MG | TABLET | Actual shortage | 2025-03-06 | 2025-04-30 | 252084 |
| TEVA-DONEPEZIL | 5MG | TABLET | Resolved | 2024-03-21 | 2024-05-23 | 222941 |
| TEVA-DONEPEZIL | 10MG | TABLET | Resolved | 2017-08-01 | 2018-05-11 | 17878 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2023-08-17 | 2023-10-04 | 202249 |
| TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42632 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42635 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2022-01-07 | 2022-01-13 | 152414 |
| TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2020-07-09 | 2020-08-21 | 119898 |
| TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2020-10-08 | 2020-11-19 | 126032 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2024-03-07 | 2024-04-18 | 221543 |
| TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2024-09-05 | 2025-02-03 | 236805 |
| TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176857 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |